Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness involves genetics, hormones, and needs better treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Finasteride made hair thicker on the back of the head in men with hair loss.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Male hair loss is mainly due to thinner hair, not less hair.

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Early-onset male baldness is significantly linked to a higher risk of metabolic syndrome.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

There is no significant link between male pattern baldness and insulin resistance.

Sex-determining genes may affect male baldness.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Botulinum toxin is not effective for treating male hair loss.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Dutasteride is safe and effective long-term for male hair loss.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Immune activities and specific genes are important in male pattern baldness.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

AR gene not major factor in female hair loss; different from male hair loss.